首页> 外国专利> CXCR3 AS EPIGENETIC MARKER FOR THE IDENTIFICATION OF INFLAMMATORY IMMUNE CELLS, IN PARTICULAR CD8+ MEMORY T CELLS

CXCR3 AS EPIGENETIC MARKER FOR THE IDENTIFICATION OF INFLAMMATORY IMMUNE CELLS, IN PARTICULAR CD8+ MEMORY T CELLS

机译:CXCR3作为表观遗传标志物,用于鉴定炎症免疫细胞,特别是CD8 +记忆T细胞

摘要

The present invention relates to a method, in particular an in vitro method, for specifically identifying the C-X-C motif chemokine receptor 3 (CXCR3) subpopulation of immune cells in a sample from a mammal comprising immune cells, in particular at least one of CD8+ effector and memory T cells, T helper (Th)1 cells and natural killer T (NKT) cells, comprising analyzing epigenetic modifications/properties of (including the methylation status) of at least one CpG position in the mammalian gene region for CXCR3 according to SEQ ID No. 1, wherein a demethylation or lack of methylation of said of at least one CpG position in said gene region is indicative for said CXCR3 specific subpopulation of immune cells in said sample, when compared to other immune cells, in particular for at least one of CD8+effector and memory T cells, T helper (Th)1 cells and natural killer T (NKT) cells. The analyses according to the invention can identify the above cells on an epigenetic level and distinguish them from all other cells in complex samples, such as, for example, other blood or immune cells. The present invention furthermore provides an improved method for quantifying the above cells, in particular in complex samples. The method can be performed without a step of purifying and/or enriching cells, preferably in whole blood and/or non-trypsinized tissue.
机译:本发明涉及一种方法,特别是一种体外方法,用于特异性地鉴定来自包含免疫细胞的哺乳动物的样品中的免疫细胞的免疫细胞亚群,特别是至少一种CD8 +效应器和内存T细胞,T辅助杆(TH)1细胞和天然杀伤T(NKT)细胞,包括根据SEQ ID的CXCR3中哺乳动物基因区域中至少一个CPG位置的(包括甲基化状态)的表观遗传修饰/性能第1号,其中所述除甲基化或缺乏所述基因区域中的CPG位置的甲基化是指示在与其他免疫细胞相比所述样品中的所述免疫细胞的所述CXCR3特异性亚群,特别是至少一个CD8 +效应和记忆T细胞,T辅助杆(TH)1细胞和天然杀伤T(NKT)细胞。根据本发明的分析可以在表观遗传水平上鉴定上述细胞,并将它们与复杂样品中的所有其他细胞区分开,例如其他血液或免疫细胞。此外,本发明还提供了一种用于量化上述细胞的改进方法,特别是在复杂的样品中。可以在没有纯化和/或富集细胞的步骤的情况下进行该方法,优选在全血和/或非胰蛋白酶化组织中。

著录项

  • 公开/公告号EP3802879A1

    专利类型

  • 公开/公告日2021-04-14

    原文格式PDF

  • 申请/专利权人 PRECISION FOR MEDICINE GMBH;

    申请/专利号EP20190723768

  • 发明设计人 OLEK SVEN;HELD JOSEPHIN;

    申请日2019-05-10

  • 分类号C12Q1/6883;

  • 国家 EP

  • 入库时间 2022-08-24 18:13:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号